Longevity companies led the effort to boost access to unapproved drugs in the state, but hurdles and safety concerns linger.

Pre-clinical trials of the Cancer Vaccine showed promising results in halting tumor growth and spread. The human trials will ...

Cancer patients will get personalised drugs made at their bedside under new laws, The Telegraph can reveal. The UK is the ...

A multinational biopharmaceutical corporation, Bristol-Myers Squibb Company (NYSE:BMY) is engaged in product discovery, ...

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

For the HF patient with a gain in LVEF, there’s little guidance on how best to care for them or manage their GDMT.

Zoryve’s regulatory and commercial success, together with pipeline progress, supports Arcutis Biotherapeutics’ positive Q2 ...

The FDA has approved VIZZ, a once-daily, preservative-free eye drop that improves near vision in adults with presbyopia for up to 10 hours.

Donanemab, approved by the FDA in 2024 to treat Alzheimer's disease, is a monoclonal antibody directed at N-terminally ...

Explore life-changing cancer care. Dr. Udai Kammula, who leads the solid tumor cell therapy program at UPMC Hillman Cancer ...

Experts warn against the risks of diphenhydramine, suggesting safer alternatives for allergy relief with fewer side effects ...

With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.